Clinical Trial Update: ObinutuzuMab AtezOlizumab and VenetocLax in RichTer transfOrmation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a triple therapy of obinutuzumab, atezolizumab, and venetoclax for Richter transformation in chronic lymphocytic leukemia; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Richter Syndrome

Drugs mentioned

• Atezolizumab (atezolizumab)
• Obinutuzumab (obinutuzumab)
• Venetoclax (venetoclax)

Snippet

Sponsor: Niguarda Hospital | Conditions: CLL Transformation | Phase 2 | Status: ACTIVE_NOT_RECRUITING